PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Cancer Immunotherapy and Immunobiology Center, Hadassah-Hebrew University Medical Center, 9112001, Jerusalem, Israel. harnoy@immunovative.com.\', \'Immunovative Therapies, Ltd, Malcha Technology Park, B1/F1, 9695101, Jerusalem, Israel. harnoy@immunovative.com.\', \'Mirror Biologics, Inc., 4824 E Baseline Rd #113, Phoenix, AZ, USA. harnoy@immunovative.com.\', \'Cancer Immunotherapy and Immunobiology Center, Hadassah-Hebrew University Medical Center, 9112001, Jerusalem, Israel.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s12967-020-02363-3
?:hasPublicationType
?:journal
  • Journal of translational medicine
is ?:pmid of
?:pmid
?:pmid
  • 32398026
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.565
?:rankingScore_hIndex
  • 81
is ?:relation_isRelatedTo_publication of
?:title
  • Allo-priming as a universal anti-viral vaccine: protecting elderly from current COVID-19 and any future unknown viral outbreak.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all